Yes. Many labs experiment with peptides as add-ons to standard treatments. The synergy can enhance the drug effect or reduce side effects.
Clinical Trial Overviews
Early-phase trials measure safety and dosage. Later phases evaluate how effectively the combination addresses a condition compared to the standalone drug.
Risk Management Tactics
Researchers track potential harmful interactions. Adequate monitoring helps prevent adverse events or minimize them before large-scale implementation.
